ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 51 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2023. The put-call ratio across all filers is 4.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,321 | +15.7% | 4,100 | 0.0% | 0.00% | – |
Q1 2023 | $2,870 | -0.9% | 4,100 | 0.0% | 0.00% | – |
Q4 2022 | $2,895 | +189.5% | 4,100 | +1071.4% | 0.00% | – |
Q3 2022 | $1,000 | – | 350 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 350 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 350 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | -33.3% | 350 | -22.2% | 0.00% | – |
Q3 2021 | $3,000 | -25.0% | 450 | -10.0% | 0.00% | – |
Q2 2021 | $4,000 | -100.0% | 500 | -50.0% | 0.00% | – |
Q1 2021 | $8,320,000 | +207900.0% | 1,000 | +100.0% | 0.00% | – |
Q4 2020 | $4,000 | -20.0% | 500 | 0.0% | 0.00% | – |
Q3 2020 | $5,000 | -37.5% | 500 | 0.0% | 0.00% | – |
Q2 2020 | $8,000 | +100.0% | 500 | 0.0% | 0.00% | – |
Q1 2020 | $4,000 | -50.0% | 500 | 0.0% | 0.00% | – |
Q4 2019 | $8,000 | -11.1% | 500 | 0.0% | 0.00% | – |
Q3 2019 | $9,000 | -18.2% | 500 | 0.0% | 0.00% | – |
Q2 2019 | $11,000 | 0.0% | 500 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $11,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $11,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 2,183,795 | $36,906,000 | 26.83% |
ORACLE INVESTMENT MANAGEMENT INC | 4,213,152 | $71,202,000 | 13.37% |
Selkirk Management LLC | 697,610 | $11,790,000 | 3.21% |
GRIFFIN ASSET MANAGEMENT, INC. | 994,657 | $16,810,000 | 2.36% |
Chicago Capital, LLC | 1,314,093 | $22,208,000 | 1.36% |
OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $2,620,000 | 0.69% |
CHARTIST INC /CA/ | 64,765 | $1,094,529,000 | 0.67% |
Cannell & Co. | 1,095,439 | $18,513,000 | 0.66% |
Trellus Management Company, LLC | 22,500 | $380,000 | 0.64% |
Belpointe Asset Management LLC | 271,514 | $4,589,000 | 0.58% |